Allogene Therapeutics Inc (ALLO)
Operating Expenses
$184.96M
TTM · Period ending: · USD
ALLO Operating Expenses
Latest reported$184.96Mperiod ending
Latest reported$184.96Mperiod ending
ALLO TTM Operating Expenses ($192.84M → $184.96M)
TTM operating expenses
High-resolution chart · PNG
ALLO operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 184,957,000 | |
| 190,216,000 | |
| 209,315,000 | |
| 227,401,000 | |
| 254,274,000 | |
| 268,886,000 | |
| 269,666,000 | |
| 294,306,000 | |
| 281,978,000 | |
| 291,109,000 | |
| 324,260,000 | |
| 335,551,000 | |
| 358,643,000 | |
| 354,761,000 | |
| 335,692,000 | |
| 313,215,000 | |
| 308,396,000 | |
| 302,789,000 | |
| 294,282,000 | |
| 289,700,000 | |
| 280,021,000 | |
| 272,106,000 | |
| 258,243,000 | |
| 253,456,000 | |
| 240,427,000 | |
| 223,230,000 | |
| 202,008,000 | |
| 170,479,000 | |
| 137,655,000 | |
| 226,706,000 | |
| 192,842,000 | |
| 159,798,000 |